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http://dx.doi.org/10.1016/j.stemcr.2016.07.017SUMMARYLimited availability of human neurons poses a significant barrier to progress in biological and preclinical studies of the human nervous
system. Current stem cell-based approaches of neuron generation are still hindered by prolonged culture requirements, protocol
complexity, and variability in neuronal differentiation. Here we establish stable human induced neural stem cell (hiNSC) lines through
the direct reprogramming of neonatal fibroblasts and adult adipose-derived stem cells. These hiNSCs can be passaged indefinitely and
cryopreserved as colonies. Independently of media composition, hiNSCs robustly differentiate into TUJ1-positive neurons within
4 days, making them ideal for innervated co-cultures. In vivo, hiNSCs migrate, engraft, and contribute to both central and peripheral
nervous systems. Lastly, we demonstrate utility of hiNSCs in a 3D human brainmodel. Thismethod provides a valuable interdisciplinary
tool that could be used to develop drug screening applications as well as patient-specific diseasemodels related to disorders of innervation
and the brain.INTRODUCTION
Much of our understanding of the human nervous system
is derived from animal studies as well as in vitro monocul-
ture of various neural cell types. However, these studies do
not truly recapitulate the complexity of human central and
peripheral nervous systems, especially at the interface with
different cell types. As such, there is a critical need to
develop more physiologically relevant in vitro human
models of the brain and innervated tissues.
One current cell source for neural tissue engineering ap-
plications is digested human brain tissue. Primary human
neural cells harvested from fetal and cadaver samples
often pose challenging ethical concerns and are unstable
in culture. Commercially available cell lines have been
produced to overcome this problem through the immor-
talization of some of these cell types such as ReNcell
VM Human Neural Progenitor Cell Line, which is derived
from the ventral mesencephalon region of a fetal brain
(Donato et al., 2007). However, immortalized lines often
function differently from their in vivo counterparts and
are not suitable for certain applications such as the gener-
ation of specific disease models due to the lack of available
brain samples from affected individuals. The discovery of
induced pluripotent stem cell (iPSC) technology revolu-
tionized the field of stem cell biology (Takahashi and Ya-
manaka, 2006). Introduction of the four reprogramming
factors, octamer-binding transcription factor 4 (OCT4),
SRY (sex-determining region Y) box 2 (SOX2), Kruppel-
like factor 4 (KLF4), and c-MYC, into somatic cells under
defined conditions results in iPSCs which, similarly to hu-Stem Cell Rep
This is an open access article under the Cman embryonic stem cells (hESCs), have the capacity to
subsequently differentiate into cell types of all three
germ layers. A number of protocols have been developed
to differentiate iPSCs into various neuronal phenotypes
such as motor (Dimos et al., 2008) or dopaminergic (Cai
et al., 2010) neurons. However, these protocols are often
very time consuming, require multiple complicated inter-
mediate steps such as the formation of non-adherent
embryoid bodies and neurospheres (Jiang et al., 2012),
and result in a large variability in neuronal differentiation
(Hu et al., 2010). These issues associated with iPSC-
derived neurons make them unsuitable for many biomed-
ical applications.
Various groups have established methods to directly
reprogram induced neurons (iNs) while omitting the PSC
stage. Pang et al. (2011) demonstrated that forced expres-
sion of BRN2, ASCl1, MYT1l, and NEUROD1 converted
human fibroblasts to induced neurons capable of gener-
ating action potentials. Pereira et al. (2014) used a similar
approach to yield human iNs (hiNs) capable of surviving
transplantation into the adult rat brain. This method of
direct reprogramming of somatic cells into induced neu-
rons circumvents some of the issues associated with iPSC-
derived neurons, including teratoma formation resulting
from a pluripotent intermediate and the extended time
frame required for differentiation. Nevertheless, hiNs
retain some significant challenges. Direct reprogramming
into neurons is often inefficient, resulting in a relatively
low yield of differentiated neurons (Ambasudhan et al.,
2011). Furthermore, because neurons are terminally differ-
entiated, hiNs are also unable to proliferate, thereby posingorts j Vol. 7 j 557–570 j September 13, 2016 j ª 2016 The Authors. 557
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Method of Reprogramming Human Cells into Induced Neural Stem Cells
(A) Protocol for generating hiNSCs. Scale bars, 100 mm.
(B) hiNSCs cultured as colonies on MEF feeders in the presence of high levels of FGF will proliferate indefinitely. Once removed from feeders,
dissociated from colonies into single cells, and subsequently cultured in medium with reduced levels of FGF, hiNSCs exclusively and
spontaneously differentiate into neurons and glia. This rapid and robust differentiation makes them uniquely suitable for high-throughput
assays and tissue engineering strategies.issues with respect to generating a sufficient supply of cells
for subsequent applications.
Further advances in cellular reprogramminghave resulted
in the generation of induced neural stem cells (iNSCs),
whichdonotpose the risks associatedwith iPSCsbut, unlike
terminally differentiated iNs, are capable of self-renewal.
Various methods of generating human iNSCs (hiNSCs)
have been described that utilize one ormore of the standard
pluripotent transcription factors (Lee et al., 2015; Wang
et al., 2013a; Zhu et al., 2014). While significant progress
has been made, there are issues among these techniques,
such as the ability to expand and cryopreserve hiNSCs
without affecting proliferative and differentiation capac-
ities, relative ease of reprogramming and subsequent differ-
entiation protocols, and discrepancies in overall efficiency.
This study describes a simple and efficient protocol for
generating stable hiNSC lines by the direct reprogramming
of primary human cells. This method results in the forma-
tion of hiNSC colonies that can be expanded indefinitely
and cryopreservedwithout any discernible loss in prolifera-
tion or capacity for differentiation. While previous tech-
niques of generating hiNSCs require multiple subsequent
differentiation steps with strict media requirements, the
ease of the protocol described hereinmakes it an ideal solu-
tion to some of the issues associated with other methods.
Once removed from mouse embryonic fibroblasts (MEFs)558 Stem Cell Reports j Vol. 7 j 557–570 j September 13, 2016and dissociated into single-cell suspension, hiNSCs
robustly differentiate into 80%–90% bIII-tubulin
(TUJ1)-, MAP2-, and NEUN-positive neurons in as few as
4 days, independently of media composition. Lastly,
hiNSCs injected into an in vivo chick embryo model
demonstrated the ability tomigrate, engraft, andcontribute
to the formation of both the central and peripheral nervous
systems, suggesting that these hiNSCs retain their neuronal
phenotype in vivo even in non-neurogenic microenviron-
ments. As a proof of concept, we demonstrate the utility
of these cells in co-culture with skeletal muscle as well as a
3D tissue model of the human brain. Taken together, the
positive attributes of reprogrammed hiNSC lines make
them ideal for future biomedical applications such as
high-throughput drug assays, complex innervated co-cul-
tures, and 3D models using normal and diseased cells.RESULTS
hiNSC Colonies Exhibit Characteristics of Both hESCs
and hNSCs
Reprogramming human neonatal dermis-derived fibro-
blasts or adult adipose-derived stem cells using a polycis-
tronic virus expressing OCT4, KLF4, SOX2, and c-MYC in
defined media on an MEF feeder layer (Figure 1) results in
the formation of colonies that exhibit qualities of hESCs as
well as hNSCs (for reprogramming efficiency, see Figure S1).
Like hESCs, these colonies immunostain positive for
OCT4, SOX2, and NANOG; however, they do not express
cell-surface markers of pluripotency SSEA4 or TRA-1-81
(Figure 2A), suggesting that these reprogrammed colonies
are not truly pluripotent. PCR analysis revealed that while
reprogrammed hiNSC colonies express the pluripotent
transcription factor NANOG, they also express relatively
high levels of endogenous SOX2 expression, but not that
of endogenous OCT4 (Figure 2B), providing further evi-
dence of the lack of a pluripotent state. SOX2 has been
shown to be a marker of self-renewing, multipotent NSCs
(Ellis et al., 2004; Graham et al., 2003), and its endogenous
upregulation is suggestive of an NSC fate. It is also impor-
tant to note that exogenous transgene expression of the
polycistronic virus is lost upon increased passage of the col-
onies and that resulting hiNSCs retain a normal karyotype
(Figure S1). While hESCs have the capacity to differentiate
into cells of all three germ layers, hiNSCs do not express
markers of endoderm or mesoderm (Figure S1), providing
further evidence of their specific ectodermal fate. Further-
more, while both undifferentiated hESC and hiNSC grow
in tightly packed colonies with clear margins, their respec-
tive morphologies differ (Figure 2C). Growing on MEF
feeders, hESC colonies appear relatively flat, while hiNSC
colonies more closely resemble neurospheres and are
dome-like in shape.
While hiNSC colonies share certain similarities with
hESC, they also share multiple characteristics with neural
stem cells. One criterion of NSCs is the ability to self-renew.
Reprogrammed hiNSCs grown as colonies on MEFs show
an average of between 46% and 60% KI67-positive cells
for all clonal lines tested (Figure 2D). Furthermore, immu-
nostaining results demonstrate that clonal lines express
various markers typical of NSCs including SOX1, PAX6,
NESTIN, and CD133 (Figure 2E). Compared with various
established human neural cell lines including H9 hESC-
derived NSC (H9-NSC) and immortalized neural progeni-
tors from fetal brain tissue (hNP), clonal hiNSC lines also
express a range of standard NSCmarkers to varying degrees
(Figure 2F). While there is inherent variability between re-
programmed clonal hiNSC lines, it is also important to
recognize the existing variability in expression between
established and commercially available neural cell lines,
which suggests that there is not a specific gold standard
for distinguishing suitable neural precursors.
hiNSCs Rapidly and Spontaneously Differentiate into
Multiple Neuronal and Glial Subtypes
Upon removal of hiNSC colonies from feeders, dissociation
into single-cell suspension and subsequent culture in me-
dia without basic fibroblast growth factor (bFGF), hiNSCsbecomemostly TUJ1-positive in as few as 4days (Figure 3A).
They also begin to express glial fibrillary acidic protein
(GFAP). By day 4, hiNSCs derived from neonatal dermal fi-
broblasts exhibited approximately 89% TUJ1-positive and
9% GFAP-positive cells, which increased to 90% and
33%, respectively, by day 14. In hiNSCs generated from
adult adipose-derived stem cells, day-4 cells were 78%
TUJ1- and 1% GFAP-positive, which increased to 92%
and 12%, respectively, by day 14. Spontaneously differenti-
ated hiNSCs also expressed other standard markers of
neuronal and glial differentiation including MAP2,
NEUN, and S100 (Figure S2).
While rapid TUJ1 expression is favorable, it is important to
further characterize the resulting neuronal phenotypes (Fig-
ure 3B). Rat embryonic neurons (RENs) derived from E18
rat brain is a common cell type used in tissue engineering
(Tang-Schomer et al., 2014). When cultured under condi-
tions similar to those for hiNSCs, RENsmostly stain positive
for vesicular glutamate transporter 2 (VGLUT2) (48%), fol-
lowed by vesicular GABA transporter (VGAT) (37%), while
very few stain positive for tyrosine hydroxylase (TH) (4%).
Similarly, hiNSCs generated from neonatal dermal fibro-
blasts and adult adipose-derived stem cells exhibit a
relatively high percentage of VGLUT+ (55% and 54%, re-
spectively) as well as VGAT+ (60% and 40%, respectively).
The ability to form synapses is an important indicator of
neuronal maturity. Spontaneously differentiated hiNSCs
express inhibitory post-synaptic marker GEPHYRIN,
as well as excitatory post-synaptic marker PSD95
(Figure 3C). They also express synaptic vesicle protein
SYNAPTOPHYSIN and voltage-gated sodium channels (Fig-
ure 3D), which is indicative of their likely ability to fire
action potentials.
Characterization of spontaneously differentiated sub-
types of glial cells revealed the presence of myelinated neu-
rons (myelin basic protein [MBP] positive). Furthermore,
culturing hiNSCs for 8 days in fetal bovine serum (FBS)-
based media supplemented with 100 mM retinoic acid
(RA) resulted in high levels of S100b astrocyte marker
expression and oligodendrocyte marker, O4 (Figure 3E),
thereby demonstrating that reprogramming by this
method results in tripotent hiNSCs.
For a number of biomedical applications, it is crucial that
cells are sustainable in long-term culture. hiNSCs cultured
for 5 weeks still express high levels of both TUJ1 and
GFAP, and maintain a healthy neuronal morphology with
elongated neurite extensions (Figure 3F).
Differentiated hiNSCs Are Functional In Vitro
While differentiated hiNSCs express various markers of
mature neurons and glia within a relatively short period
of time, it is important to also test functionality. One
week after removal from MEFs, hiNSCs cultured on gelatinStem Cell Reports j Vol. 7 j 557–570 j September 13, 2016 559
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Figure 2. Clonal hiNSC Colonies Display Characteristics of Both ESCs and NSCs
(A) H1 hESC colonies express all pluripotent markers while reprogrammed hiNSC clonal lines express markers OCT4, SOX2, and NANOG, but
not SSEA4 or TRA-1-81.
(B) Gene-expression profile comparing H1 hESC with hiNSC clonal lines. Data represent mean ± SD of three independent experiments.
(C) Morphology of hESC colonies compared with hiNSC. hiNSCs exhibit a domed morphology.
(D) KI67 immunostaining reveals a large percentage of proliferating cells within hiNSC colonies.
(legend continued on next page)
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demonstrated the morphology of immature neurons (Fig-
ure 4A), characterized by cell bodies in the early stages of
axon development. Fluo-4 calcium imaging of hiNSCs re-
veals that they have detectable levels of functional calcium
signaling at this early time point (Figure 4B). Furthermore,
electrophysiology results reveal that 1-week cultured cells
have a resting membrane potential of approximately
50 mV (which corresponds to reported Vmem values of
immature neurons (Ben-Ari et al., 2007) and that they
demonstrate a depolarizing response to the GABA agonist,
muscimol (Figure 4C), suggesting that theyhave functional
GABA receptors and that they respond in a manner similar
to that of typical immature neurons.
Fluo-4 calcium imaging of 2-week-old cultures reveals
that spontaneous calcium signaling is increased and that
it is significantly activated in response to picrotoxin, an es-
tablished blocker of inhibitory GABA receptors (Figure 4D).
Because activation of GABA receptors inhibits neuronal
firing, blockage of these receptors causes an increase in
firing. Therefore, hiNSCs cultured for 1–2 weeks respond
to well-characterized pharmaceuticals, as expected based
on studies in animals and other in vitro neuron systems.
Given the short amount of time required to elicit these
functional responses, hiNSCs should have future applica-
bility in high-throughput drug studies.
The gold standard for in vitro functionality of neurons is
the ability to fire action potentials. hiNSCs were cultured
on poly-L-lysine-coated coverslips for 8 weeks (Figure 4E),
then subjected to electrophysiological analysis. Current-
clamp recordings showed that the average resting mem-
brane potential of recorded cells was between 50 and
70 mV. Differentiated hiNSCs displayed the ability to
generate action potentials in response to depolarizing cur-
rent steps (Figure 4F) as well as spontaneous action poten-
tials (Figure 4G), thereby fully demonstratingmaturity and
functionality in vitro.
hiNSCs Migrate, Engraft, and Maintain Neuronal
Phenotype In Vivo
To assay the ability of hiNSCs to survive and differentiate
in vivo, we utilized the chick embryo (Figure 5A). In brief,
hiNSCs were dissociated, labeled, and injected into the
neural tube of a 2.5-day-old chicken embryo. Embryos
were allowed to grow for 1–8 days post transplantation
and then harvested for analysis. After 24 hr, fluorescently
labeled hiNSCs can be visualized within the primitive
head region (Figure 5B). Six days after injection of hiNSCs,
embryos were harvested and analyzed for incorporation of(E) hiNSC colonies express NSC markers, PAX6, SOX1, NESTIN, and CD
(F) Gene-expression profile comparing expression of NSC markers in com
Data represent mean ± SD of three independent experiments.
All scale bars, 100 mm. See also Figures S1 and S6.hiNSCs into the peripheral nervous system (Figures 5C–
5C00). Immunostaining results of sagittal cryosections of
the developing limb reveal the presence of human cells as
indicated by positive staining of human nuclear antigen
(HUNU). High-magnification images show that HUNU-
positive cells co-localized with the neural stem cell marker,
NESTIN. In addition, certain HUNU-positive cells also co-
localized with homeobox transcription factor HB9, which
plays a critical role in motor neuron differentiation during
development, and with E1.9 (NF) antibody staining, which
recognizes neurofilament protein expressed in sensory and
motor axons (Stainier andGilbert, 1990). This suggests that
hiNSCs can contribute to the formation of the developing
peripheral nervous system, and that they maintain their
neuronal phenotype even in the presence of a mixed
population of non-neuronal cells. Injected hiNSCs also
contributed to the developing spine (Figure S5). Eight
days after injection of hiNSCs, embryos were harvested
and analyzed for incorporation of hiNSCs into the CNS
(Figures 5D–5D00). Cryosections of the cranial region show
HUNU-positive cells atmultiple locations within the devel-
oping brain. Higher-magnification images demonstrate
that HUNU-positive cells exclusively co-localized with
TUJ1. In addition, some HUNU-positive cells present in
the brain also co-expressed markers of GABAergic (VGAT)
as well as glutamatergic (VGLUT2) neurons. Importantly,
this demonstrates that hiNSCs can contribute to the CNS,
and can differentiate into various subtypes of neurons
in vivo. To date, few studies have demonstrated in vivo
incorporation of hiNSCs into the developing CNS as well
as the peripheral nervous system (PNS) extending into
non-neuronal tissues.
hiNSCs Have Multiple Applications in Tissue
Engineering
For cultured human neurons to be successfully incorpo-
rated into various tissue engineering models, it is crucial
that theymaintain their phenotype inmultiple cell-culture
media types and in differentiated co-cultures. hiNSCs
grown in generic culture medium DMEM + 10% FBS are
also mostly neuronal in phenotype (Figure 6A), with 89%
TUJ1+, 60% MAP2+, 20% GFAP+, and 20% S100+. This
robust differentiation even in undefined media suggests
that hiNSCs can be incorporated into a variety of co-culture
models for which FBS is the main supplement.
One example of a common cell type grown in FBS-based
media is C2C12, an established murine myoblast cell line.
C2C12 cells proliferate in DMEM supplemented with 10%133.
mercially available human NSC lines with that of hiNSC clonal lines.
Stem Cell Reports j Vol. 7 j 557–570 j September 13, 2016 561
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Figure 3. hiNSCs Rapidly Differentiate into Various Neuronal and Glial Phenotypes
(A) Expression of neuron-specific bIII-tubulin (TUJ1) and glial fibrillary acidic protein (GFAP) in hiNSC clonal lines derived from HFF and
hASC at 4 and 14 days. The large panel displays a merged image of TUJ1, GFAP, and DAPI; inlaid insets reveal separate images of TUJ1 (top)
and GFAP (bottom). By 4 days, more than 80% of cells stain positive for neuron markers. Scale bars, 100 mm.
(B) hiNSCs spontaneously differentiate into subtypes of neurons. Embryonic rat brain-derived neurons are shown as a positive control.
Scale bars, 50 mm.
(C) hiNSCs express post-synaptic proteins at both inhibitory (GEPHYRIN and VGAT) and excitatory (PSD95 and VGLUT1) synapses. Scale
bars, 10 mm.
(D) hiNSCs spontaneously express synaptic vesicle protein, SYNAPTOPHYSIN, and voltage-gated sodium channel marker PAN-NAV. Scale
bars, 100 mm.
(E) hiNSCs differentiate into multiple types of glia including astrocytes (S100b), oligodendrocytes (O4), and myelin marker positive glia
(MBP). Scale bars, 100 mm.
(F) hiNSCs maintain neuronal and glial phenotypes in long-term cultures. Scale bars, 100 mm. Data in (A) and (B) represent mean ± SD of
three independent experiments. See also Figures S2–S4 and S6.FBS. When grown at high confluence and switched to low
serum conditions (1% FBS), cells begin to fuse and form
mature skeletal myotubes. C2C12 cells were grown in
co-culture with hiNSCs in DMEM + 1% FBS for 4–5 days.
Immunostaining analysis reveals the presence of differenti-
ated myosin heavy chain (MHC)-positive myotubes,
non-overlapping expression of TUJ1-positive hiNSCs with562 Stem Cell Reports j Vol. 7 j 557–570 j September 13, 2016neurite extensions (Figure 6B), and the formation of a-bun-
garotoxin-positive neuromuscular junctions. Co-cultured
hiNSCs also began to express ISLET1/2, transcription fac-
tors that promote motor neuron differentiation, as well as
4E2, a marker of Schwann cell protein found in regene-
rating nerves at the site of neuromuscular junctions
(Astrow et al., 1994).
Figure 4. hiNSCs Are Functional In Vitro
(A) Bright-field image of hiNSCs cultured for 1 week on gelatin. Scale bar, 100 mm.
(B) Calcium imaging of hiNSCs demonstrates active calcium signaling after 1 week.
(C) Electrophysiology recordings show that hiNSCs cultured for 1 week have functional GABA receptors that demonstrate depolarization in
response to the GABA agonist muscimol.
(D) At 2 weeks of culture, hiNSCs display a significant increase in calcium signaling in response to picrotoxin. Data represents mean ± SD
from eight cell traces.
(E–G) Bright-field image of hiNSCs (E) cultured for 8 weeks on poly-L-lysine-coated coverslips. Scale bar, 100 mm. Patch-clamp elec-
trophysiology results demonstrate that hiNSCs elicit both current-induced (F) and spontaneous (G) action potentials.To test the ability of hiNSCs to integrate into a 3D envi-
ronment, we incorporated them into the 3D cortical brain
tissue model established by our laboratory, which had pre-
viously used embryonic rat-derived cortical neurons. Our
3Dbrainmodel consists of an aqueous silk scaffold inwhich
the center is removed to create a donut-shaped construct
(Figure 6C). This scaffold, which serves as the gray matter
of the brain, is then coatedwith laminin. hiNSCs are seeded
and allowed to adhere overnight. Calcein imaging of live
cells 24 hr after seeding cells within the scaffold show local-
ization of hiNSCs inside the silk sponge (Figure 6D). The
following day, a collagen gel is added to the center to allow
for neurite growth, thereby simulating the white matter ofthe brain. 3D cultures were fixed after 3 weeks in culture
and immunostained for TUJ1, revealing the presence of
elongated neurite extensions within the collagen gel (Fig-
ure 6E). Furthermore, hiNSCs seeded into the 3D brain
model exhibited active firing as visualized by Fluo-4 cal-
cium signaling (see also Movie S1), thereby demonstrating
functionality of these neurons in 3D.DISCUSSION
This study describes a simplified protocol for the efficient
generation of hiNSCs via direct reprogramming. hiNSCStem Cell Reports j Vol. 7 j 557–570 j September 13, 2016 563
Figure 5. hiNSCs Migrate, Engraft, and Differentiate into Both the PNS and CNS In Vivo
(A) Schematic of injection method. hiNSC colonies were dissociated into single-cell suspension, fluorescently labeled using DiD, and
injected into the entire lumen of the developing neural tube of 55-hr-old chicken embryos (in ovo). Embryos were harvested between 1
and 8 days for subsequent analysis.
(B) Arrowhead shows fluorescently labeled hiNSCs in the cranial region 24 hr post injection. Scale bar, 500 mm.
(C) Embryos were harvested at 6 days post injection and the developing limbs were cryosectioned. Scale bar, 1 mm.
(C0 and C00) Rectangular outlines in (C0) reflect magnified areas shown in (C00). Arrowheads indicate the presence of human cells as indicated
by human nuclear antigen (HUNU) immunostaining, which co-localizes with NESTIN, HB9 (a marker of developing motor neurons), and NF
(neurofilament of sensory and motor axons) in the developing limb. Scale bars, 500 mm in (C0) and 100 mm in (C00).
(D) Embryos were harvested at 8 days post injection and the head region cryosectioned. Scale bar, 5 mm.
(D0 and D00) Rectangular outlines in (D0) reflect magnified areas shown in (D00). Arrowheads reveal the presence of HUNU-positive cells,
which broadly co-localized with TUJ1 as well as neuronal subtype-specific markers VGAT (GABAergic) and VGLUT2 (glutamatergic) in the
developing brain. Scale bars, 1 mm in (D0) and 100 mm in (D00).
See also Figure S5.lines grow as colonies on MEF feeder layers. Like hESCs,
hiNSCs stain positive for pluripotent transcription factors
OCT4, SOX2, and NANOG, but do not express cell-surface
markers SSEA4 and TRA-1-81, suggesting that these hiNSC
clonal lines are not truly pluripotent. In a previous study
using fluorescence-activated cell sorting to derive NSCs564 Stem Cell Reports j Vol. 7 j 557–570 j September 13, 2016from H9 hESCs, only TRA-1-60/SSEA4 cells could form
neurospheres, suggesting that hESCs lacking these markers
specifically adopt a neuroectodermal cell fate (Chaddah
et al., 2012). All clonal lines tested showed an increase in
endogenous SOX2 expression, but not endogenous OCT4
expression. Previous studies of various types of NSCs
have demonstrated that the maintained expression of
SOX2 and the absence of OCT4 is one of the hallmarks of
NSCs (Graham et al., 2003; Mistri et al., 2015). Clonal lines
generated by ourmethod result in a highly pure population
of hiNSCs lacking these pluripotent markers, providing
further evidence of their NSC identity.
Studies have shown that the introduction of pluripotent
factors under certain conditions yields iPSCs and not
iNSCs. This protocol of directly reprogramming somatic
cells into hiNSCs differs from the protocol used to generate
iPSCs in several ways. First is the use of xeno-free serum
replacement (SR). Rajala et al. (2007) tested nine different
types of xeno-free culture media and found that none
were able to maintain undifferentiated growth of hESCs,
demonstrating a lack of pluripotency. While the xeno-
free knockout (KO)-SR may contribute to the adoption of
a stable non-pluripotent cell fate, another likely reason is
the relatively high levels of bFGF. Neural induction from
iPSCs has been shown to require very high levels of FGF
(up to 100 ng/mL) (Nemati et al., 2011). Our method of re-
programming hiNSCs results in the formation of colonies
that resemble the neurosphere stage, which relies mostly
on high levels of FGF. The third factor is the use of MEFs
in conjunction with xeno-free KO-SR and high FGF. MEF
feeder layers have been shown to be crucial in maintaining
the proliferation of undifferentiated stem cells (Thomson
et al., 1998). It is plausible that the MEF feeder layers are
helping to promote continuous self-renewal of hiNSCs
while the xeno-free SR, which lacks the ability to maintain
pluripotency of cells, and the high levels of FGF work in
combination to promote the neural stem cell fate.
We are not the first investigators to describe a protocol for
generating hiNSCs.Most protocols to generate hiNSCs that
utilize similar reprogramming genes use them as separate
factors (Wang et al., 2013a, 2013b). As such, there is an
increased chance of variability with respect to controlling
the relative expression of exogenously introduced genes
that can accompany the use ofmultiple expression vectors.
By using a singular polycistronic lentivirus, the relative
expression and stoichiometry of the introduced factors is
held constant in every round of reprogramming. Lastly,
because our method could be used to successfully repro-
gram somatic cells from two different tissues, it is possible
that it may also be utilized for other starting cell types. Pre-
vious studies have described the generation of hiNSCs;
however, few have demonstrated the applicability of their
respective protocols in reprogramming multiple cell types
(Lee et al., 2015; Wang et al., 2013a; Zhu et al., 2015). For
example, a method was described to reprogram urine-
derived epithelial cells, but the same protocol could not
be used to reprogram fibroblasts (Wang et al., 2013a). We
fully acknowledge that herein we have only described the
generation of hiNSC lines from two different starting celltypes. It remains to be seen whether this method can effec-
tively reprogram other starting cell types or whether it is
restricted to human fibroblasts and adipose-derived stem
cells.
Aside from the benefits of the actual protocol, our
method also results in hiNSCs with multiple favorable
properties including a seemingly endless capacity for self-
renewal. hiNSC colonies grown on MEF feeders are app-
roximately 50% positive for proliferation marker Ki67,
a characteristic that does not change upon increased pas-
sage (Figure S6). Many previously described hiNSCs cannot
be fully expanded in vitro. Serial passaging of NSCs gener-
ated from hematopoietic progenitors showed a decrease in
the level of NESTIN staining in cells by passage 7 (Wang
et al., 2013b, 2015). Clonal hiNSC lines generated by this
method can be expanded indefinitely as colonies (>30 pas-
sages to date) and frozen and thawed without any discern-
ible loss in capacity for differentiation (Figure S6). hiNSC
lines have been validated by the expression of the NSC
markers PAX6, SOX1, NESTIN, and CD133 by immuno-
staining, as well as other conventional NSC markers quan-
tified by qRT-PCR (Figure 2). Gene-expression analysis
demonstrates that these clonal lines all express detectable
levels of these markers to varying degrees. It is possible
that this variability is functionally relevant. For example,
SOX1 expression was considerably higher in hiNSCs
derived from adult adipose compared with those derived
from neonatal dermis. SOX1 was found to play a critical
role in the derivation of NSCs fromhuman adipose-derived
mesenchymal stem cells (Feng et al., 2014). Inhibition of
SOX1 expression greatly reduced the resulting NSC yield,
suggesting that SOX1may also play a role in the induction
of hiNSCs from adipose cells using our method. While
there may be some level of variability between clonal
hiNSC lines, there is also inherent variability between
well-established neural cell lines (Figure 2F), suggesting
that there is no benchmark gene-expression profile for
human NSCs. All clonal lines tested express NSC-specific
markers and do not express markers of other germ layer
lineages (Figure S1), indicating that reprogrammed hiNSC
colonies are truly neuroectodermal in fate.
While hiNSC colonies have a high proliferative capacity,
their subsequent capacity for neuronal and glial differenti-
ation is equally as robust. hiNSCs generated by thismethod
do not require strict post-reprogramming media compo-
nents or procedures, unlikemany recently described hiNSC
strategies. While some protocols of hiNSC differentiation
require the formation of an intermediate non-adherent
neurosphere step (Lee et al., 2015; Wang et al., 2013a),
ours does not. For the purposes of tissue engineering this
is ideal, as the transition from suspension to adherent sub-
strates can be difficult (Marshall et al., 2008), and the core
of neurospheres can often become necrotic (Cahan andStem Cell Reports j Vol. 7 j 557–570 j September 13, 2016 565
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Figure 6. Tissue Engineering Applications Using hiNSCs
(A) hiNSCs differentiate into mostly neuronal and glial phenotypes in various media types. Dissociated hiNSCs grown in undefined medium
(DMEM + 10% FBS) for 8 days are 90% positive for neuronal marker TUJ1. Scale bars, 100 mm. Data represent means ± SD of three
independent experiments.
(B) hiNSCs can be co-cultured with other differentiated cell types while still maintaining neuron-specific expression. C2C12, a murine
myoblast cell line, was differentiated and co-cultured with hiNSCs for 4–5 days. hiNSCs remained TUJ1-positive in co-culture with
differentiating skeletal muscle cells. Co-cultures also exhibited positive a-bungarotoxin (a-BTX) immunostaining (arrowheads),
(legend continued on next page)
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Daley, 2013). Furthermore, most methods require specific
media components to both differentiate and maintain a
neuronal phenotype in culture. While previous hiNSC
studies have reported TUJ1 immunostaining after 4 weeks
of differentiation in specific media types supplemented
with factors such as BDNF and GDNF (Zhu et al., 2014,
2015), our hiNSC colonies, once trypsinized off of feeders,
dissociated, and subcultured on different substrates, begin
to differentiate into a high percentage of TUJ1-positive
immature neurons and begin to express glial markers in
as few as 4 days, independently of media composition. At
this early time point they also highly expressed differenti-
ated neuron markers MAP2 and NEUN (Figure S2). Upon
differentiation, there was variability between hiNSCs
derived fromneonatal dermis comparedwith adult adipose
in that dermally derived hiNSCs generated a higher propor-
tion of glia. This discrepancy could be due to random vari-
ability between clonal lines, the donor cells being neonatal
versus adult, or the different tissues of origin from which
starting cells were harvested. Danielyan et al. (2007) re-
ported that GFAP expression is detectable in human skin
sections and in cultured fibroblasts. It is possible that
dermally derived hiNSCs have a higher capacity for
GFAP expression as they may retain cellular memory
from their original tissue. Despite this slight variability in
glia formation, hiNSCs still have wide utility for multiple
applications.
Further analysis of subtype specification of hiNSCs indi-
cated that after 2 weeks in culture, hiNSCs spontaneously
differentiate into mostly glutamatergic and GABAergic
neurons, and do not express high levels of the dopa-
minergic neuron marker TH. While these subtypes were
obtained from spontaneous differentiation in generic neu-
robasalmedia supplementedwith B27,wehave shown that
differentiation can also be directed. Culturing hiNSCs in
the presence of certain combinations of Sonic hedgehog
(Shh), FGF8, and/or RA resulted in the upregulation of mo-
tor neuron marker HB9, dopaminergic neuron marker TH,
or glial marker GFAP (Figures S3 and S4), suggesting that
while hiNSCs spontaneously differentiate into neurons
and glia, this differentiation can be further guided by the
addition of growth factors to generate specific neural and
glial subtypes. Future studies using hiNSCs could be con-indicative of the presence of nicotinic acetylcholine receptors (AChRs)
co-cultures began to express markers of motor neurons (HB9) as well
(C) Incorporation of hiNSCs into a 3D brain model. This model consists
laminin. Cells are seeded into this outer ring and allowed to attach.
which allows for neurite growth and extension.
(D) Calcein staining of donuts 24 hr post seeding. Scale bar, 300 mm
(E) TUJ1 immunostaining showing neurite extensions into the collag
(F) Snapshot of live calcium signaling in 3D brain cultures.
See also Movie S1.ducted to identify other potential factors that could be
added to basalmedia to differentiate specific types of neural
and/or glial cells, or to develop co-culture systems with
other relevant cell types to induce various types of tissue-
specific neurons.
At later time points, spontaneously differentiated
hiNSCs expressed post-synaptic markers of both inhibitory
and excitatory synapses as well as synaptic vesicle protein
SYNAPTOPHYSIN, suggesting that hiNSCs can form
functional synapses (Tarsa and Goda, 2002). hiNSCs also
expressed voltage-gated sodium channels, which is sugges-
tive of their ability to fire action potentials. Not only do
hiNSCs spontaneously differentiate into various subtypes
of neurons, they also differentiate into multiple types of
glia cells including astrocytes and oligodendrocytes.
While hiNSCs express variousmarkers ofmature neurons
and synapses as detected via immunostaining, it is crucial
to validate their functionality. One week after removal
from MEFs, hiNSCs exhibit detectable levels of calcium
signaling as well as functional GABA receptors, as indicated
by a depolarizing response to the GABA agonist muscimol
(Figure 4), suggesting that they behave as physiologically
immature neurons even at this early time point. hiNSCs
differentiated for longer periods displayed the ability to
generate both current-induced and spontaneous action po-
tentials, thereby demonstrating their functionality in vitro.
While most in vivo validation studies involve the trans-
plantation of neural cells into the brain of neonatal and/
or adult rodent models followed by assay of neural marker
expression after several weeks, we wanted to utilize an
in vivo model in which we could specifically examine the
ability of hiNSCs to rapidly incorporate into both the
CNS and PNS. The chick embryo allows for the migration
of cells throughout the entire developing neural tube, sup-
porting subsequent integration into both the brain and
non-neural tissues, which is not amenable to rodent
models. Our study is not the first to utilize a chick embryo
model to assay neural cell incorporation in vivo. Kharazi
et al. (2013) demonstrated the ability of human fetal
brain-derived NSCs to engraft into the lateral ventricle of
chick embryonic brain. Another study transplanted mouse
ESC-derivedmotor neurons into chick embryos to visualize
extensions from the spinal cord into the peripheryfound in neuromuscular junctions. Differentiating hiNSCs in muscle
as Schwann cell-associated antigen (4E2/3G2). Scale bars, 100 mm.
of a silk sponge cut into the shape of a donut, which is coated with
Once attached, a collagen gel is added to the center of the donut,
.
en gel in 3-week 3D brain cultures. Scale bar, 100 mm.
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(Wichterle et al., 2009). Our model targeted the CNS and
PNS by directly injecting hiNSCs into the entire lumen of
the neural tube, allowing for growth into both the head
and periphery. This in vivo model is more rigorous, as it
challenges the cells to maintain their neuronal phenotype
even in a microenvironment that may not be conducive to
neurogenesis. All human cells assayed that stained positive
for human nuclear antigen (HUNU) exclusively co-local-
ized with NESTIN or TUJ1 (n = 227). It is important to
note that neural crest cells, which migrate from the neural
tube into peripheral tissues, have the capacity to become
multiple cell types including melanocytes, cartilage,
bone, and smooth muscle, as well as peripheral and enteric
neurons and glia (Le Douarin et al., 2007). Upon injection
into the chick neural tube, hiNSCs maintained neuronal
lineage even when growing outside the brain; however, it
is essential to address the limitations of this in vivo system
compared with traditional rodent models. While we
demonstrate in vitro that hiNSCs cannot be induced to
differentiate into endodermal or mesodermal germ layers
(Figure S1) and that upon culturing hiNSCs in permissive
cell-culturemedia for the amount of time typically required
for teratoma formation there is no spontaneous induction
of pluripotent factor OCT4 or germ layer markers (Fig-
ure S6), this does not exclude the possibility that hiNSCs
could ultimately result in teratoma formation when trans-
planted in vivo for multiple weeks. It should also be
acknowledged that neural stem cells engrafted in rodent
brains typically require several months to differentiate.
Because hiNSCs generated by our method differentiate so
quickly, it will be important to ensure that they also do
not result in tumorigenesis and/or neural overgrowth
upon transplantation into an adult rodent brain.
Given the robust capacity of these hiNSCs to maintain
neuronal phenotype even in non-neuronal conditions,
hiNSCs are highly desirable for multiple tissue engineering
applications. When removed from MEF feeders and sub-
sequently grown in generic medium DMEM + 10% FBS,
hiNSCs express more than 90% TUJ1+ neurons, suggesting
that they do not require neuron-specific media to become
neurogenic, a feature that has not been explored with other
recently described methods of generating iNSCs (Lee et al.,
2015; Zhu et al., 2015). This maintenance of neuronal
phenotype is very favorable for complex co-cultures where
other cell typesmayhave strictmedia requirements.Asproof
of principle, we co-cultured differentiating C2C12 skeletal
muscle cells with hiNSCs under conditions favorable for
the differentiation of C2C12. Both cell types differentiated,
expressing their respective markers MHC and TUJ1 in a
non-overlapping pattern, suggesting that both cell types
can successfully differentiate in co-culture and maintain
their individual phenotypes. Muscle neuron co-cultures
also expressed a-bungarotoxin, which is suggestive of the568 Stem Cell Reports j Vol. 7 j 557–570 j September 13, 2016presence of nicotinic acetylcholine receptors commonly
found at the neuromuscular junction. Furthermore, co-
cultured hiNSCs expressed motor neuron-specific ISLET1/2
as well as amarker of Schwann cells, suggesting that perhaps
the presence of muscle cells guides the specification of adja-
cent hiNSCs. hiNSCs can be utilized to develop other physi-
ologically relevant human innervated co-culture systems.
The ability of hiNSCs to grow and demonstrate function-
ality in a 3D model is also quite remarkable. We have previ-
ously described our 3D brain donut model using embryonic
rat brain neurons (Chwalek et al., 2015; Tang-Schomer et al.,
2014). Recent studies have developed 3Dmodels for the cul-
ture of human neural cells, but have their limitations. A 3D
human neural cell-culture model of Alzheimer’s disease
was developed by overexpressing human b-amyloid precur-
sor protein and/or presenilin1 (PSEN1) in immortalized
human fetal NSCs (ReNcell) (Choi et al., 2014). However,
in vitro differentiation of this model required 6–12 weeks,
and this technique does not allow for the incorporation of
patient-specific cells. Pasca et al. (2015)describeda 3Dmodel
of functional cortical neurons and astrocytes derived from
human iPSCs; however, the time required to generate these
models (between52and137days)makes this type of 3Dcul-
turequite prohibitive forhigher-throughput applications. In
our 3Dbrainmodel seededwith hiNSCs, we see long neurite
extensionsasearlyas2weeks,whichdemonstrate functional
calcium signaling (see Movie S1).
While this technique of generating stable and rapidly
differentiating hiNSC lines has many advantages, in its cur-
rent form this method of reprogramming may not be suit-
able for clinical applications due to the presence of MYC
and animal products. However, because this lentivirus con-
tains an excisable cassette that can be removed upon addi-
tion of Cre-recombinase, itmay not pose the risk of incorpo-
rating into the host genome. Furthermore, future efforts can
bemade to further adapt theprotocol tobe completelyxeno-
free. It is also important to acknowledge that the require-
ment of feeder layers for the derivation of these lines adds a
layer of complexity that should be addressed upon further
optimization of this method. Because the neurons derived
from thismethod are so robust, they are currently amenable
to a variety of high-throughput drug screening assays. In
addition, future experiments can be performed to incorpo-
rate these hiNSCs into other 3D tissue models in which a
neuronal component would be relevant, such as the skin
and cornea, as well as disease models of the human brain.EXPERIMENTAL PROCEDURES
Generation of hiNSCs
Human neonatal foreskin fibroblasts (HFFs) (a gift from
Dr. Jonathan Garlick, Tufts University) or adult human adipose-
derived stem cells (hASCs) isolated as previously described (Abbott
et al., 2015) were used to generate hiNSCs. In brief, HFFs or hASCs
were plated at a concentration of 105 cells in one gelatin-coated
well of a 6-well plate, and cultured in fibroblast medium (DMEM,
10% FBS, and 1% antibiotic-antimycotic). Concentrated virus
was used to infect the cells in fibroblast medium with polybrene
(Millipore) at an MOI of 1–2. The next day, medium was changed
to fresh fibroblast medium. The following day, medium was
changed to hiNSC medium: knockout (KO) DMEM supplemented
with 20% KO xeno-free SR, 20 ng/mL recombinant bFGF, 1%
Glutamax, 1% antibiotic-antimycotic, and 0.1 mM b-mercaptoe-
thanol, which also contained 1% KO growth factor cocktail
(GFC) (Invitrogen). Four days later, cells were trypsinized and re-
plated on MEF feeder layers previously inactivated by mitomycin
C. hiNSC medium (without KO-GFC) was subsequently changed
every 1–3 days. At day 30 or later, colonies with a domed
morphology were mechanically picked and passaged onto freshly
mitotically inactivated MEFs. Each colony was used to generate
one hiNSC line, which was expanded as colonies on MEF feeders.
For further expansion, hiNSCs were enzymatically passaged as
colonies using trypsin-like enzyme, TrypLE (Invitrogen), onto
new MEF feeders for multiple passages, and subsequently frozen
to make stocks.
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